Basic science offers a challenge for developing hemoglobin based oxygen carriers into therapeutic agents

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 39, Issue 4, 2011, Pages 206-213

  Bucci, Enrico ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Blood substitutes; Facilitate diffusion; NO scavenging; Oxygen delivery; Vasoconstriction

Indexed keywords

BASIC SCIENCE; EXPERIMENTAL DATA; FACILITATE DIFFUSION; HEMOGLOBIN-BASED OXYGEN CARRIERS; OXYGEN AFFINITY; OXYGEN DELIVERY; THERAPEUTIC AGENTS; VASOCONSTRICTION;

CURRICULA; HEMOGLOBIN; NITRIC OXIDE;

OXYGEN;

HEMOGLOBIN BASED OXYGEN CARRIER; HEMOGLOBIN DERIVATIVE; NITRIC OXIDE; OXYGEN; UNCLASSIFIED DRUG;

ARTICLE; DRUG DEVELOPMENT; DRUG HALF LIFE; DRUG RETENTION; EXPERIMENTAL STUDY; HUMAN; HYPEROXIA; OXYGEN AFFINITY; SCAVENGING SYSTEM; SCIENCE; VASOCONSTRICTION;

ANIMALS; BLOOD SUBSTITUTES; DRUG DISCOVERY; FREE RADICAL SCAVENGERS; HEMOGLOBINS; HUMANS; NITRIC OXIDE; OXYGEN; TIME FACTORS;

EID: 79959954970     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.3109/10731199.2010.538402     Document Type: Article

References (36)

1. Natanson, C., Kern, S.J., Lurie, P., Banks, S.M., Wolfe, S.M. (1998). Cell free hemoglobin-based blood substitutes and risk of myocardial infarctions and death. JAMA 299: 2304-12.
2. Bucci, E. (2009). Thermodynamic approach to oxygen delivery in vivo by natural and artifi cial oxygen carriers. Biophysical Chemistry 142:1-6.
3. Bucci E (2010) Oxygen delivery by natural and artifi cial oxygen carriers. Chemistry and Biochemistry of Oxygen Therapeutics: from transfusions to blood substitutes. Bettati and Mozzarelli editors, Wiley. In press.
4. Bucci, E., Watts, T.L., Kwansa, H.E., Fasano, A. (2003). A different effi cacy in vitro of hemoglobin-based carriers and red cells. Adv. Exp. Med. Biol. 510:89-92. (Pubitemid 36307759)
5. Wittenberg, J.W. (1966). The molecular mechanism of hemoglobin- facilitated oxygen Diffusion. J. Biol. Chem. 241:104-114.
6. Urbaitis, B.K., Razynska, A., Corteza, Q., Fronticelli, C., and Bucci, E. (1991). Intravascular retention and renal handling of purifi ed natural and intramolecularly crosslinked hemoglobins. J. Lab. Clin. Med., 117:115-121.
7. Ulatowski, J.A., Nishikawa, T., Matheson-Urbaitis, B., Bucci, E., Traystman, R.J., Koehler, R.C. (1996). Regional blood flow alterations after bovine fumaryl beta betacrosslinked hemoglobin transfusion and nitric oxide synthase inhibition. Crit Care Med. 24:558-65. (Pubitemid 26133787)
8. Asano, Y., Koehler, R.C., Ulatowski, J.A., Traystman, R.J., Bucci, E. (1998). Effect of crosslinked hemoglobin transfusion on endothelial dependent dilation in feline pial arterioles. Am J Physiol Heart Circ Physiol 275: H1313-H1321.
9. Rippe, B., and Haraldsson, B. (1994). Transport of macromolecules across microvascular walls the two-pore theory. Physiol Rev 74:163-219. (Pubitemid 24045677)
10. 2 carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol 279:H908-H915.
11. Cabrales, P., Sun, G., Zhou, Y., Harris, D.R., Tsai, A.G., Intaglietta, M., and Palmer, A.F. (2009). Effects of the molecular mass of tense-state polymerized bovine hemoglobin on blood pressure and vasoconstriction. J Appl Physiol 107:1548-1558.
12. Matheson, B., Kwansa, H.E., Bucci, E., Rebel, A., Koehler, R.C. (2002). Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Physiol 93: 1479-1486.
13. Yu, B., Raher, M., Volpato, G.P., Bioch, K.D., Ichinose, F., Zapol, W.M. (2008). Inhaled nitric oxide enables artifi cial blood transfusion without hypertension. Circulation 117: 1982-1980.
14. 2 carriers. Microvasc Res. 66:49-58. (Pubitemid 36765444)
15. Ulatowski, J.A., Bucci, E., Nishikawa, T., Razynska, A. Williams, A., Takeshima, R., Traystman, R.J. and Koehler, R. C. (1996). Cerebral O 2 transport with hematocrit reduced by cross-linked hemoglobin transfusion. Am. J. Physiol. (Heart Circ. Physiol. 39) 270:466-475.
16. Ulatowski, J.A., Bucci, E., Razynska, A., Traystman, R.J., Koehler, R.C. (1998). Cerebral blood flow during hypoxic hypoxia with plasma-based hemoglobin at reduced hematocrit. Am J Physiol 274:H1933-1942.
17. 2. Am J Physiol Heart Circ Physiol. 285:H1600-H1608. (Pubitemid 37169515)
18. Sampei, K., Ulatowski, J.A., Asano, Y., Kwansa, H., Bucci, E., Koehler, R.C. (2005). Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion. Am J Physiol Heart Circ. Physiol. Sep; 289 (3):H1191-1201. (Pubitemid 41208963)
19. Qin, X., Kwansa, H., Bucci, E., Roman, R.J., Koehler, R.C. (2006). Role of 20-HE TE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobin. J. Appl Physiol. 100:336-342. (Pubitemid 43671126)
20. Page, T.C., Light, W.R., McKay, C.B., Hellums, J.D. (1998). Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobinbased oxygen carrier performance. Microvasc. Res. 55:54-64. (Pubitemid 28368413)
21. Baldwin, A.L. (1999). Modified hemoglobins produce venular interendothelial gaps and albumin leakage in the ratmesentery. Am. J. Physiol. 277:H650-H659. (Pubitemid 29415979)
22. Dull, R.D., DeWitt, B.J., Dinavahi, R., Schwartz, L., Hubert, C., Pace, N., Fronticelli, C. (2004). Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction. J. Appl. Physiol. 97:1930-1937. (Pubitemid 39426013)
23. Bucci, E., Fronticelli, C. (1995). Hemoglobin intramolecularly cross-linked with long chain divalent reagents. U.S. Patent #5, 387, 672.
24. Fronticelli, C., Koehler, C. (2009). Design of recombinant hemoglobins for use in transfusion fluids. Crit.Care Clin. 25: 357-71.
25. Koehler, R.C., Fronticelli, C., Bucci, E. (2008). Independence of oxygen transport on oxygen affi nity of hemoglobin-based oxygen carriers. Biochem Biophys Acta 1784: 1387-94.
26. Kwansa, H.E., Arosio, D., and Bucci, E. (2000). Adipyl crosslinked bovine hemoglobins as new models for allosteric transitions. Proteins: Structure, Function and Genetics 39:166-169. (Pubitemid 30176483)
27. Buehler, P.V., Boykins, R.A., Jia, Y., Norris, S., Freedberg, I.D., and Alayash, A.I. (2003). Structural and functional characterization of glutaraldehyde-polymerized bovine hemoglobin and its isolated fractions. Anal. Chem. 77: 3466-3478.
28. Vandegriff, K.D., Malavalli, A., Wooldridge, J., Lohman, J., Winslow, R.M. (2003). MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion. 43:509-516. (Pubitemid 36428335)
29. Acharya, S.A., Friedman, J.M., Manjula, B.N., Intaglietta, M., Tsai, A.G., Winslow, R.M., Malavalli, A., Vandegriff, K., Smith, P.K. (2005). Enhanced molecular volume of conservatively pegylated Hb: (SP-PEG5K)6-HbA is nonhypertensive. Artif Cells Blood Substit Immobil Biotechnol. 33:239-55. (Pubitemid 41190931)
30. Vandegriff, K.D., Young, M.A., Lohman, J., Bellelli, A., Samaja, M., Malavalli, A., and Winslow, R.M. (2008). COMP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br. J. Pharmacol. 154:1649-1661.
31. Klaus, J.A., Kibler, K.K., Abuchowski, A., Koehler, R.C. (2010). Early treatment of transient focal cerebral ischemia with bovine PEGylated carboxy hemoglobin transfusion. Artif Cells Blood Substit Immobil Biotechnol. (in press). [Epub ahead of print].
32. Kawaguchi, A.T., Nakai, K., Fukumoto, D., Yamano, M., Haida, M., Tsukada, H. (2009). S-nitrosylated pegylated hemoglobin reduces the size of cerebral infarction in rats. Artif Organs 33:183-188.
33. Asanuma, H., Nakai, K., Sanada, S., et al. (2007). S-nitrosylated and pegylated hemoglobin, a newly developed artifi cial oxygen carrier, exerts cardioprotection against ischemic hearts. J Mol Cell Cardiol 42: 924-930. (Pubitemid 46678028)
34. Motterlini, R., Clark, J.E., Foresti, R., Sarathchandra, P., Mann, B.E., Green, C.J. (2002). Carbon monoxidereleasing molecules: characterization of biochemical and vascular activities. Circ Res. 90:E17-E24.
35. Yu, B., Shahid, M., Egorina, E.M., Sovershaev, M.A., Raher, M.J., Lei, C., Wu, M.X., Bloch, K.D., Zapol, W.M. (2010). Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by hemoglobin-based oxygen carrier. Anesthesiology. 112:586-594.
36. Kohmoto, J., Nakao, A., Stolz, D.B., Kaizu, T., Tsung, A., Ikeda, A., et al. (2007). Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway. Am J Transplant. 7:2279-2290. (Pubitemid 47347863)